Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy

被引:23
作者
Huang, Zhentai [2 ]
Jiang, Jianfei [2 ]
Belikova, Natalia A. [2 ]
Stoyanovsky, Detcho A. [2 ]
Kagan, Valerian E. [2 ]
Mintz, Arlan H. [1 ]
机构
[1] Univ Pittsburgh, Shadyside Hosp, Dept Neurosurg, Pittsburgh, PA 15232 USA
[2] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15260 USA
关键词
Glioblastoma; Mitochondria; Triphenyl-phosphonium conjugated nitroxide; gamma-irradiation; Apoptosis; IN-VITRO; RADIATION; TEMPOL; RADIOTHERAPY; GLIOMAS; RADIOPROTECTORS; SUPEROXIDE; INHIBITION; REDUCTION; STRESS;
D O I
10.1007/s11060-010-0387-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma multiforme is the most frequent and aggressive primary brain tumor. A strong rationale to identify innovative approaches to treat these tumors is required since treatment failures result in local recurrences and median survivals range from 9 to 12 months. Glioma cells are reported to have less mitochondrial content compared to adjacent normal brain cells. Based on this difference, we suggest a new strategy, utilizing protection of normal brain cells by mitochondria-targeted electron scavengers and antioxidants-nitroxides-thus allowing for the escalation of the radiation doses. In this paper, we report that a conjugate of nitroxide with a hydrophobic cation, triphenyl-phosphonium (TPEY-Tempo), significantly protected brain endothelial cells from gamma-irradiation-induced apoptosis while radiosensitizing brain tumor cells. Thus, TPEY-Tempo may be a promising adjunct in the treatment of glioblastoma with the potential to not only prolong survival but also to maintain quality of life and reduce treatment toxicity.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 26 条
[1]   SUPEROXIDE AND HYDROGEN-PEROXIDE IN RELATION TO MAMMALIAN-CELL PROLIFERATION [J].
BURDON, RH .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (04) :775-794
[2]  
CHANG CH, 1983, CANCER-AM CANCER SOC, V52, P997, DOI 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO
[3]  
2-2
[4]   Radioprotectors and Mitigators of Radiation-Induced Normal Tissue Injury [J].
Citrin, Deborah ;
Cotrim, Ana P. ;
Hyodo, Fuminori ;
Baum, Bruce J. ;
Krishna, Murali C. ;
Mitchell, James B. .
ONCOLOGIST, 2010, 15 (04) :360-371
[5]   RADIATION-INDUCED APOPTOSIS - RELEVANCE TO RADIOTHERAPY [J].
DEWEY, WC ;
LING, CC ;
MEYN, RE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04) :781-796
[6]   Reduction of the transcription level of the mitochondrial. genome in human glioblastoma [J].
Dmitrenka, V ;
Shostak, K ;
Boyka, O ;
Khomenko, O ;
Rozumenko, V ;
Malisheva, T ;
Shamayev, M ;
Zozulya, Y ;
Kavsan, V .
CANCER LETTERS, 2005, 218 (01) :99-107
[7]   Study of in vitro and in vivo effects of the piperidine nitroxide Tempol -: a potential new therapeutic agent for gliomas [J].
Gariboldi, MB ;
Ravizza, R ;
Petterino, C ;
Castagnaro, M ;
Finocchiaro, G ;
Monti, E .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (06) :829-837
[8]   In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides [J].
Hahn, SM ;
DeLuca, AM ;
Coffin, D ;
Krishna, CM ;
Mitchell, JB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :839-842
[9]   IDENTIFICATION OF NITROXIDE RADIOPROTECTORS [J].
HAHN, SM ;
WILSON, L ;
KRISHNA, CM ;
LIEBMANN, J ;
DEGRAFF, W ;
GAMSON, J ;
SAMUNI, A ;
VENZON, D ;
MITCHELL, JB .
RADIATION RESEARCH, 1992, 132 (01) :87-93
[10]   Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector [J].
Hahn, SM ;
Krishna, MC ;
DeLuca, AM ;
Coffin, D ;
Mitchell, JB .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (06) :953-958